Anti-Müllerian hormone level in older women : Detection of granulosa cell tumor recurrence

20Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: To determine whether anti-Müllerian hormone (AMH) production resumes during normal late menopausal aging. Anti-Müllerian hormone has been proposed as a specific serum marker for adult granulosa cell tumors. Materials and Methods: Serum AMH from 21 elderly postmenopausal women (mean age, 77 years) and 9 young women (mean age, 22 years) were measured by ultrasensitive immunoassay. Results: Both median (0 pmol/L) and mean (0.48 pmol/L) serum AMH values for the elderly women were below the level of detection for the immunoassay kit. Three of the 21 participants had minimally detectable level of AMH (1.13-2.76 pmol/L). The cohort of young women had expected normal values of AMH as measurable by the same immunoassay kit. Conclusions: Serum AMH values were negligible for postmenopausal women older than 65 years. This extends the normative data for AMH to 108 years old, providing a reference range for the detection of granulosa cell tumors in postmenopausal women. Copyright © 2012 by IGCS and ESGO.

Cite

CITATION STYLE

APA

Chong, Y. H., Campbell, A. J., Farrand, S., & McLennan, I. S. (2012). Anti-Müllerian hormone level in older women : Detection of granulosa cell tumor recurrence. International Journal of Gynecological Cancer, 22(9), 1497–1499. https://doi.org/10.1097/IGC.0b013e318270ac69

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free